Previous 10 | Next 10 |
home / stock / invvy / invvy news
Indivior PLC ADR press release ( OTCPK:INVVY ): Q2 Non-GAAP EPS of $0.06. Revenue of $221M (+10.0% Y/Y). Outlook: Total FY 2022 expected NR range maintained at $840M to $900M (+10% vs. FY 2021 at the mid-point); Adjusted gross margin expected to be in the low- to mid-8...
Indivior Announces H1 and Q2 2022 Financial Results PR Newswire SLOUGH, U.K. and RICHMOND, Va. , July 28 , 2022 /PRNewswire/ -- Indivior PLC (LON: INDV) today announced its financial results for the period ending June 30, 2022 . The earnings ...
Indivior Names Nina DeLorenzo Chief Global Impact Officer PR Newswire RICHMOND, Va. , June 16, 2022 /PRNewswire/ -- Indivior PLC (LON: INDV) announces the appointment of Nina DeLorenzo as Chief Global Impact Officer. DeLorenzo will serve on the Execut...
The following slide deck was published by Indivior PLC in conjunction with this event. For further details see: Indivior (INVVY) Presents At Jefferies Healthcare Conference - Slideshow
Indivior Announces Seven Abstracts Accepted for Presentation at the 84th Annual Scientific Meeting of the College on Problems of Drug Dependence (CPDD) PR Newswire RICHMOND, Va. , June 9, 2022 /PRNewswire/ -- Indivior PLC (LON: INDV) today announced ...
Indivior Announces First Patient Included in Aelis Farma's Phase 2b Study Assessing the Efficacy, Safety and Tolerability of AEF0117 in Treatment-Seeking Subjects With Moderate to Severe Cannabis Use Disorder PR Newswire SLOUGH, England and RICHMOND, Va. , ...
For Mental Health Awareness Month, Indivior Offers Hope for Opioid Use Disorder Recovery Through One Man's Inspiring Story PR Newswire RICHMOND, Va. , May 19, 2022 /PRNewswire/ -- May is Mental Health Awareness Month, a time to increase understanding of t...
Indivior Lends Voice to Help Raise Awareness of Substance Use Disorder During Mental Health Awareness Month and National Fentanyl Awareness Day PR Newswire RICHMOND, Va. , May 10, 2022 /PRNewswire/ -- May is Mental Health Awareness Month, a time to increa...
Indivior PLC (INVVY) Q1 2022 Results Earnings Conference Call April 28, 2022, 08:00 AM ET Company Participants Mark Crossley - Chief Executive Officer Ryan Preblick - Chief Financial Officer Christian Heidbreder - Chief Scientific Officer Conference Call Participants Paul Cuddon - Numis Secur...
The following slide deck was published by Indivior PLC in conjunction with their 2022 Q1 earnings call. For further details see: Indivior PLC 2022 Q1 - Results - Earnings Call Presentation
News, Short Squeeze, Breakout and More Instantly...
Indivior to Host Analyst Teach-in Event in New York City; Reconfirms Full Year 2024 Guidance PR Newswire RICHMOND, Va. , May 23, 2024 /PRNewswire/ -- Indivior PLC (LSE: INDV; Nasdaq: INDV), a leading addiction treatment company, announced that in anticipation o...
Indivior Announces Q1 2024 Financial Results PR Newswire SLOUGH, United Kingdom and RICHMOND, Va. , April 25, 2024 /PRNewswire/ -- Indivior PLC (LSE/Nasdaq: INDV) today announced its financial results for the period ending March 31, 2024 . The earnings re...
Indivior Announces Publication Demonstrating that OPVEE® (nalmefene) Nasal Spray Rapidly Reverses Effects of Opioid-Induced Respiratory Depression in Head-to-Head Study Against Intranasal Naloxone PR Newswire This head-to-head pharmacodynamic study in healthy volunteers...